Reversal of pain by group II metabotropic glutamate receptors

II 类代谢型谷氨酸受体逆转疼痛

基本信息

  • 批准号:
    8255236
  • 负责人:
  • 金额:
    $ 5.13万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2011
  • 资助国家:
    美国
  • 起止时间:
    2011-12-01 至 2014-11-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Inflammation or injury can sensitize nociceptive neurons and the resulting hyperexcitability is thought to mediate increased pain sensation. Although pain typically resolves with time, the mechanisms that promote the return to Dr. g are poorly understood. Dysfunction of such a mechanism could contribute to the persistence of chronic pain, while activation could provide relief from pain. The central hypothesis of this proposal is that peripheral group II metabotropic glutamate receptors (mGluRs) regulate the reversal of nociceptor sensitization and hyperalgesia. This hypothesis will be tested with a combination of anatomical, neurophysiological, and behavioral methods. Two subtypes of group II mGluRs exist, mGluR2 and mGluR3. The specific expression of each subtype within dorsal root ganglia (DRG) will be characterized. We will then determine whether mGluR2 or mGluR3 is necessary for the normal recovery from inflammatory and neuropathic pain using mGluR2 and mGluR3 knockout mice. We propose that group II mGluRs can reverse nociceptor sensitization. To test this, patch-clamp techniques will be used to measure neuronal excitability in sensitized DRG neurons. After pharmacological manipulation of group II mGluRs excitability will be reassessed. Membrane excitability is determined by current flux through ion channels, but it is not clear whether group II mGluRs regulate currents involved in sensitization. Two candidate currents, the tetrodotoxin- resistant Na+ and T-type Ca2+ current will be tested for their ability to be modulated by group II mGluRs in sensitized DRG neurons. We hypothesize that group II mGluRs are involved in the endogenous recovery from hyperalgesia. To test this, we will determine whether positive allosteric modulators of group II mGluRs accelerate the recovery from inflammatory hyperalgesia. Finally, we will determine whether group II mGluRs are capable of relieving ongoing neuropathic pain using an operant conditioning paradigm.
描述(由申请人提供):炎症或损伤可使伤害性神经元敏感,由此产生的高兴奋性被认为介导疼痛感觉的增加。虽然疼痛通常会随着时间的推移而消退,但促使患者回到g医生身边的机制却知之甚少。这种机制的功能障碍可能导致慢性疼痛的持续,而激活可以缓解疼痛。该提议的中心假设是外周II组代谢谷氨酸受体(mGluRs)调节伤害感受器致敏和痛觉过敏的逆转。这一假设将通过解剖学、神经生理学和行为学方法的结合来检验。II组mGluRs存在两种亚型,mGluR2和mGluR3。每个亚型在背根神经节(DRG)内的具体表达将被表征。然后,我们将使用mGluR2和mGluR3敲除小鼠来确定mGluR2或mGluR3对于炎症性和神经性疼痛的正常恢复是必需的。我们认为II组mglur可以逆转伤害感受器致敏。为了验证这一点,膜片钳技术将用于测量敏化DRG神经元的神经元兴奋性。在药理学操作后,将重新评估II组mGluRs的兴奋性。膜兴奋性是由通过离子通道的电流通量决定的,但尚不清楚II组mGluRs是否调节参与敏化的电流。两种候选电流,河豚毒素抗性Na+和t型Ca2+电流将测试它们在敏化DRG神经元中被II组mGluRs调节的能力。我们假设II组mglur参与痛觉过敏的内源性恢复。为了验证这一点,我们将确定II组mGluRs的阳性变构调节剂是否加速炎症性痛觉过敏的恢复。最后,我们将使用操作性条件反射范式确定II组mglur是否能够缓解持续的神经性疼痛。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Steve Davidson其他文献

Steve Davidson的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Steve Davidson', 18)}}的其他基金

Genetic and physiological comparison of native human sensory neurons and induced pluripotent stem cells differentiated to sensory neurons
天然人类感觉神经元和分化为感觉神经元的诱导多能干细胞的遗传和生理比较
  • 批准号:
    10573702
  • 财政年份:
    2022
  • 资助金额:
    $ 5.13万
  • 项目类别:
Thalamo-Limbic Circuits in Pain
疼痛中的丘脑边缘回路
  • 批准号:
    10397151
  • 财政年份:
    2018
  • 资助金额:
    $ 5.13万
  • 项目类别:
Thalamo-Limbic Circuits in Pain
疼痛中的丘脑边缘回路
  • 批准号:
    10159317
  • 财政年份:
    2018
  • 资助金额:
    $ 5.13万
  • 项目类别:
Functional Characterization and Sensitization of Human Pruriceptors
人类瘙痒感受器的功能特征和敏感性
  • 批准号:
    9035997
  • 财政年份:
    2016
  • 资助金额:
    $ 5.13万
  • 项目类别:
Reversal of pain by group II metabotropic glutamate receptors
II 类代谢型谷氨酸受体逆转疼痛
  • 批准号:
    8366988
  • 财政年份:
    2011
  • 资助金额:
    $ 5.13万
  • 项目类别:
Central Nerual Mechanisms Involved in the Control of Itch
参与控制瘙痒的中枢神经机制
  • 批准号:
    7388995
  • 财政年份:
    2007
  • 资助金额:
    $ 5.13万
  • 项目类别:
Central Nerual Mechanisms Involved in the Control of Itch
参与控制瘙痒的中枢神经机制
  • 批准号:
    7576850
  • 财政年份:
    2007
  • 资助金额:
    $ 5.13万
  • 项目类别:
Central Nerual Mechanisms Involved in the Control of Itch
参与控制瘙痒的中枢神经机制
  • 批准号:
    7275086
  • 财政年份:
    2007
  • 资助金额:
    $ 5.13万
  • 项目类别:

相似海外基金

Unraveling Adverse Effects of Checkpoint Inhibitors Using iPSC-derived Cardiac Organoids
使用 iPSC 衍生的心脏类器官揭示检查点抑制剂的副作用
  • 批准号:
    10591918
  • 财政年份:
    2023
  • 资助金额:
    $ 5.13万
  • 项目类别:
Optimization of mRNA-LNP vaccine for attenuating adverse effects and analysis of mechanism behind adverse effects
mRNA-LNP疫苗减轻不良反应的优化及不良反应机制分析
  • 批准号:
    23K15383
  • 财政年份:
    2023
  • 资助金额:
    $ 5.13万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Elucidation of adverse effects of combined exposure to low-dose chemicals in the living environment on allergic diseases and attempts to reduce allergy
阐明生活环境中低剂量化学品联合暴露对过敏性疾病的不良影响并尝试减少过敏
  • 批准号:
    23H03556
  • 财政年份:
    2023
  • 资助金额:
    $ 5.13万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Green tea-based nano-enhancer as an adjuvant for amplified efficacy and reduced adverse effects in anti-angiogenic drug treatments
基于绿茶的纳米增强剂作为抗血管生成药物治疗中增强疗效并减少不良反应的佐剂
  • 批准号:
    23K17212
  • 财政年份:
    2023
  • 资助金额:
    $ 5.13万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Effects of Tobacco Heating System on the male reproductive function and towards to the reduce of the adverse effects.
烟草加热系统对男性生殖功能的影响以及减少不利影响。
  • 批准号:
    22H03519
  • 财政年份:
    2022
  • 资助金额:
    $ 5.13万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Mitigating the Adverse Effects of Ultrafines in Pressure Filtration of Oil Sands Tailings
减轻油砂尾矿压力过滤中超细粉的不利影响
  • 批准号:
    563657-2021
  • 财政年份:
    2022
  • 资助金额:
    $ 5.13万
  • 项目类别:
    Alliance Grants
1/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
1/4-破译ECT结果和不良反应的机制(DECODE)
  • 批准号:
    10521849
  • 财政年份:
    2022
  • 资助金额:
    $ 5.13万
  • 项目类别:
4/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
4/4-破译ECT结果和不良反应的机制(DECODE)
  • 批准号:
    10671022
  • 财政年份:
    2022
  • 资助金额:
    $ 5.13万
  • 项目类别:
2/4 Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
2/4 ECT 结果和不良反应的破译机制(DECODE)
  • 批准号:
    10670918
  • 财政年份:
    2022
  • 资助金额:
    $ 5.13万
  • 项目类别:
Adverse Effects of Using Laser Diagnostics in High-Speed Compressible Flows
在高速可压缩流中使用激光诊断的不利影响
  • 批准号:
    RGPIN-2018-04753
  • 财政年份:
    2022
  • 资助金额:
    $ 5.13万
  • 项目类别:
    Discovery Grants Program - Individual
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了